Skip to main content
. 2023 Oct 22;59(10):1875. doi: 10.3390/medicina59101875

Figure 2.

Figure 2

(a) Dermic pleomorphic invasive lobular carcinoma (G3), hematoxylin–eosin 20×. (b) Positive androgen receptors, immunohistochemistry 20×. (c) Positive estrogen receptors, immunohistochemistry 20×.